Citations

Clear

3314 citation(s) found for "Yu, Alexander".

Tai Chi for patients with mild cognitive impairment
Yang, Juan , Chon, Tony Y. , Li, Guangxi , Mallory, Molly J., Bublitz, Sara E. , Do, Alexander , Xiao, Lizu, Xiong, Donglin, Bauer, Brent A. , Li, Guangxi

Mayo Clinic

Medicine | October 2, 2019 | Volume: 98 | Issue: 40 | Pages: e17118

10.1097/md.0000000000017118 | PMID 31577701 Get It

Abstract Background: Mild cognitive impairment (MCI) is an intermediate stage between the cognitive changes of normal aging and early dementia. Tai Chi (TC) may be particularly beneficial to patients with MCI due to its whole-body coordination characteristics. This systematic review protocol aims to outline the methods that will be used to assess the comparative effectiveness and safety of TC for MCI through a systematic review and meta-analysis. Methods: A systematic review will identify and evaluate randomized controlled trials (RCTs) that examined the effects and safety of TC compared to a placebo, conventional treatment, and no treatment on cognitive function in individuals with MCI. Studies from databases of MEDLINE, PubMed, Embase, Global Health, Cochrane Library, and Scopus from January 1990 to March 2019 reported in English will be searched. Two independent reviewers will screen the studies for inclusion with the eligibility criteria and extract data. Risk of bias of individual studies will be assessed in line with Cochrane risk of bias tool. The overall quality of cumulative evidence will be assessed using selected Grading of Recommendations, Assessment, Development, and Evaluations criteria. Statistics will be used for heterogeneity assessment, sensitivity analysis, data synthesis, generating funnel plots, and subgroup analysis. Meta-analysis will be performed, if sufficiently homogeneous studies are found. A narrative synthesis will be conducted, grouping studies by exposure and outcome definitions, and describing any differences by subgroups. Results: This study will provide practical and targeted evidence in investigating the impact of TC exercise for individuals with MCI. Conclusion: The findings of our study will provide updated evidence to determine whether TC is an effective intervention to patients with MCI. Trial registration number: International Prospective Register for Systematic Reviews (PROSPERO) number CRD42019125104.
Exploring the neuroregenerative potential of tacrolimus
Saffari, Tiam M. , Bedar, Meiwand , Hesselink, Dennis A. , Hundepool, Caroline A. , Zuidam, Jelle Michiel , Shin, Alexander Y. , Baan, Carla C.

Mayo Clinic

Expert Review of Clinical Pharmacology | October 2, 2019 | Volume: 12 | Issue: 11 | Pages: 1047-1057

10.1080/17512433.2019.1675507 | PMID 31575290 Get It

A Novel Multi-Target Small Molecule, LCC-09, Inhibits Stemness and Therapy-Resistant Phenotypes of Glioblastoma Cells by Increasing miR-34a and Deregulating the DRD4/Akt/mTOR Signaling Axis
Wen, Ya-Ting, Wu, Alexander T.H. , Bamodu, Oluwaseun Adebayo , Li, Wei , Lin, Chien‐Min , Chao, Tsu-Yi, Hsiao, Michael , Huang, Hsu‐Shan , Huang, Hsu-Shan , Wu, Alexander T H , Wen, Ya-Ting , Yen, Yun , Mukhopadhyay, Debabrata , Huang, Hsu-Shan

Mayo Clinic

Cancers | September 27, 2019 | Volume: 11 | Issue: 10 | Pages: 1442

10.3390/cancers11101442 | PMID 31561595 Get It

The management of glioblastomas (GBMs) is challenged by the development of therapeutic resistance and early disease recurrence, despite multi-modal therapy. This may be attributed to the presence of glioma stem cells (GSCs) which are known to survive radio- and chemotherapy, by circumventing death signals and inducing cell re-population. Recent findings suggest GSCs may be enriched by certain treatment modality. These necessitate the development of novel therapeutics capable of targeting GBM cell plasticity and therapy-resistant GSCs. Here, aided by computer-assisted structure characterization and target identification, we predicted that a novel 5-(2′,4′-difluorophenyl)-salicylanilide derivative, LCC-09, could target dopamine receptors and oncogenic markers implicated in GBMs. Bioinformatics data have indicated that dopamine receptor (DRD) 2, DRD4, CD133 and Nestin were elevated in GBM clinical samples and correlated to TMZ (Temozolomide) resistance and increased ALDH (Aldehyde dehydrogenase) activity (3.5–8.9%) as well as enhanced (2.1–2.4-fold) neurosphere formation efficiency in U87MG and D54MG GBM cell lines. In addition, TMZ-resistant GSC phenotype was associated with up-regulated DRD4, Akt, mTOR, β-catenin, CDK6, NF-κB and Erk1/2 expression. LCC-09 alone, or combined with TMZ, suppressed the tumorigenic and stemness traits of TMZ-resistant GBM cells while concomitantly down-regulating DRD4, Akt, mTOR, β-catenin, Erk1/2, NF-κB, and CDK6 expression. Notably, LCC-09-mediated anti-GBM/GSC activities were associated with the re-expression of tumor suppressor miR-34a and reversal of TMZ-resistance, in vitro and in vivo. Collectively, these data lay the foundation for further exploration of the clinical feasibility of administering LCC-09 as single-agent or combinatorial therapy for patients with TMZ-resistant GBMs.
Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder Coalition
Conley, Robert B., Adib, Gemma, Adler, Robert A. , Alexander, Ivy M. , Amenta, Kelly C, Blank, Robert D. , Brox, W. Timothy , Carmody, Emily E., Chapman‐Novakofski, Karen , Cody, Kathleen, Cooper, Cyrus , Crandall, Carolyn , Dirschl, Douglas R. , Eagen, Thomas J. , Elderkin, Ann L, Fujita, Masaki , Greenspan, Susan L., Halbout, Philippe , Hochberg, Marc C. , Jeray, Kyle J. , Kearns, Ann E. , King, Toby, Koinis, Thomas F., Koontz, Jennifer Scott , Kužma, Martin , Lindsey, Carleen, Lorentzon, Mattias , Lyritis, George P., Michaud, Laura Boehnke, Miciano, Armando S., Mujahid, Nadia , Olenginski, Thomas P. , Puzas, J. Edward, Rizou, Stavroula , Thompson, Elizabeth , Tosi, Laura L. , Tracer, Howard, Clarke, Bart L , Cooper, Cyrus , Crandall, Carolyn J , Kužma, Martin , Morin, Suzanne N , Napoli, Nicola , Khosla, Sundeep , Lorentzon, Mattias , Åkesson, Kristina , Clarke, B.L. , Javaid, M K , Rosen, Clifford J. , Saag, Kenneth G. , Khosla, Sundeep , Kiel, Douglas P.

Mayo Clinic

Journal of Bone and Mineral Research | September 20, 2019 | Volume: 35 | Issue: 1 | Pages: 36-52

10.1002/jbmr.3877 | PMID 31538675 Get It

ABSTRACT Osteoporosis-related fractures are undertreated, due in part to misinformation about recommended approaches to patient care and discrepancies among treatment guidelines. To help bridge this gap and improve patient outcomes, the American Society for Bone and Mineral Research assembled a multistakeholder coalition to develop clinical recommendations for the optimal prevention of secondary fracture among people aged 65 years and older with a hip or vertebral fracture. The coalition developed 13 recommendations (7 primary and 6 secondary) strongly supported by the empirical literature. The coalition recommends increased communication with patients regarding fracture risk, mortality and morbidity outcomes, and fracture risk reduction. Risk assessment (including fall history) should occur at regular intervals with referral to physical and/or occupational therapy as appropriate. Oral, intravenous, and subcutaneous pharmacotherapies are efficacious and can reduce risk of future fracture. Patients need education, however, about the benefits and risks of both treatment and not receiving treatment. Oral bisphosphonates alendronate and risedronate are first-line options and are generally well tolerated; otherwise, intravenous zoledronic acid and subcutaneous denosumab can be considered. Anabolic agents are expensive but may be beneficial for selected patients at high risk. Optimal duration of pharmacotherapy is unknown but because the risk for second fractures is highest in the early post-fracture period, prompt treatment is recommended. Adequate dietary or supplemental vitamin D and calcium intake should be assured. Individuals being treated for osteoporosis should be reevaluated for fracture risk routinely, including via patient education about osteoporosis and fractures and monitoring for adverse treatment effects. Patients should be strongly encouraged to avoid tobacco, consume alcohol in moderation at most, and engage in regular exercise and fall prevention strategies. Finally, referral to endocrinologists or other osteoporosis specialists may be warranted for individuals who experience repeated fracture or bone loss and those with complicating comorbidities (eg, hyperparathyroidism, chronic kidney disease). © 2019 American Society for Bone and Mineral Research.
Reply to Wand et al. : Role of Transbronchial Cryobiopsy in Interstitial Lung Diseases: An Ongoing Tale
Bourdin, Arnaud , Suehs, Carey , Colby, Thomas V. , Vachier, Isabelle , Molinari, Nicolas , Romagnoli, Micaela , Suehs, Carey M , Vachier, Isabelle , Molinari, Nicolas , Bourdin, Arnaud

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | September 19, 2019 | Volume: 201 | Issue: 2 | Pages: 260-261

10.1164/rccm.201909-1736le | PMID 31535900 Get It

Dilution of Molecular–Pathologic Gene Signatures by Medically Associated Factors Might Prevent Prediction of Resection Status After Debulking Surgery in Patients With Advanced Ovarian Cancer
Kommoss, Stefan , Tourani, Roshan , Grandelis, Anthony , Uppendahl, Locke , Aliferis, Constantin , Burges, Alexander , Wang, Chen , Canzler, Ulrich , Belau, Antje , Prader, Sonia , Hanker, Lars , Ma, Sisi , Hilpert, Felix , Schneider, Stephanie , Kimmig, Rainer , Kurzeder, Christian , Schmalfeldt, Barbara , Braicu, Elena Ioana , Harter, Philipp , Dowdy, Sean C. , Winterhoff, Boris , Pfisterer, Jacobus , Uppendahl, Locke , Burges, Alexander , Wang, Chen , Heitz, Florian , Ma, Sisi , Ataseven, Beyhan , Sehouli, Jalid , Bois, Andreas du

Mayo Clinic

Clinical Cancer Research | September 16, 2019 | Volume: 26 | Issue: 1 | Pages: 213-219

10.1158/1078-0432.ccr-19-1741 | PMID 31527166 Get It

Abstract Purpose: Predicting surgical outcome could improve individualizing treatment strategies for patients with advanced ovarian cancer. It has been suggested earlier that gene expression signatures (GES) might harbor the potential to predict surgical outcome. Experimental Design: Data derived from high-grade serous tumor tissue of FIGO stage IIIC/IV patients of AGO-OVAR11 trial were used to generate a transcriptome profiling. Previously identified molecular signatures were tested. A theoretical model was implemented to evaluate the impact of medically associated factors for residual disease (RD) on the performance of GES that predicts RD status. Results: A total of 266 patients met inclusion criteria, of those, 39.1% underwent complete resection. Previously reported GES did not predict RD in this cohort. Similarly, The Cancer Genome Atlas molecular subtypes, an independent de novo signature and the total gene expression dataset using all 21,000 genes were not able to predict RD status. Medical reasons for RD were identified as potential limiting factors that impact the ability to use GES to predict RD. In a center with high complete resection rates, a GES which would perfectly predict tumor biological RD would have a performance of only AUC 0.83, due to reasons other than tumor biology. Conclusions: Previously identified GES cannot be generalized. Medically associated factors for RD may be the main obstacle to predict surgical outcome in an all-comer population of patients with advanced ovarian cancer. If biomarkers derived from tumor tissue are used to predict outcome of patients with cancer, selection bias should be focused on to prevent overestimation of the power of such a biomarker. See related commentary by Handley and Sood, p. 9
S12-14 SESSION 12: FACIOCRANIOSYNOSTOSIS – PART II THE CLASSIFICATION OF APERT SYNDROME, BASED ON CRANIAL VAULT SUTURE SYNOSTOSIS ------DIFFERENT CRANIAL BASE ANGULATIONS AND AIRWAY COMPROMISE
Cabrejo, Raysa, Wilson, Alexander T. , Steinbacher, Derek M., Alperovich, Michael , Persing, John A. , Lu, Xiaona , Sawh‐Martinez, Rajendra , Forte, Antonio J. , Wu, Rui , Alonso, Nivaldo

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | September 9, 2019 | Volume: 7 | Issue: 8S-2 | Pages: 158-159

10.1097/01.gox.0000583732.74167.01 Get It

Deep Learning–Based Histopathologic Assessment of Kidney Tissue
Hermsen, Meyke , Bel, Thomas de , Boer, Marjolijn den, Steenbergen, Eric J., Florquin, Sandrine , Roelofs, Joris J. T. H. , Stegall, Mark D. , Alexander, Mariam P., Smeets, Bart , Laak, Jeroen van der , Stegall, Mark D , Kers, Jesper , Smith, Byron H. , Hilbrands, Luuk B.

Mayo Clinic

Journal of the American Society of Nephrology | September 5, 2019 | Volume: 30 | Issue: 10 | Pages: 1968-1979

10.1681/asn.2019020144 | PMID 31488607 Get It

Significance Statement Histopathologic assessment of kidney tissue currently relies on manual scoring or traditional image-processing techniques to quantify and classify tissue features, time-consuming approaches that have limited reproducibility. The authors present an alternative approach, featuring a convolutional neural network for multiclass segmentation of kidney tissue in sections stained by periodic acid–Schiff. Their findings demonstrate applicability of convolutional neural networks for tissue from multiple centers, for biopsies and nephrectomy samples, and for the analysis of both healthy and pathologic tissues. In addition, they validated the network’s results with components from the Banff classification system. Their convolutional neural network may have utility for quantitative studies involving kidney histopathology across centers and potential for application in routine diagnostics. Background The development of deep neural networks is facilitating more advanced digital analysis of histopathologic images. We trained a convolutional neural network for multiclass segmentation of digitized kidney tissue sections stained with periodic acid–Schiff (PAS). Methods We trained the network using multiclass annotations from 40 whole-slide images of stained kidney transplant biopsies and applied it to four independent data sets. We assessed multiclass segmentation performance by calculating Dice coefficients for ten tissue classes on ten transplant biopsies from the Radboud University Medical Center in Nijmegen, The Netherlands, and on ten transplant biopsies from an external center for validation. We also fully segmented 15 nephrectomy samples and calculated the network’s glomerular detection rates and compared network-based measures with visually scored histologic components (Banff classification) in 82 kidney transplant biopsies. Results The weighted mean Dice coefficients of all classes were 0.80 and 0.84 in ten kidney transplant biopsies from the Radboud center and the external center, respectively. The best segmented class was “glomeruli” in both data sets (Dice coefficients, 0.95 and 0.94, respectively), followed by “tubuli combined” and “interstitium.” The network detected 92.7% of all glomeruli in nephrectomy samples, with 10.4% false positives. In whole transplant biopsies, the mean intraclass correlation coefficient for glomerular counting performed by pathologists versus the network was 0.94. We found significant correlations between visually scored histologic components and network-based measures. Conclusions This study presents the first convolutional neural network for multiclass segmentation of PAS-stained nephrectomy samples and transplant biopsies. Our network may have utility for quantitative studies involving kidney histopathology across centers and provide opportunities for deep learning applications in routine diagnostics.
Outcomes of Vascularized Bone Allotransplantation with Surgically Induced Autogenous Angiogenesis in a Large Animal Model: Bone Healing, Remodeling, and Material Properties
Houben, Rudolph H. , Kotsougiani, Dimitra , Friedrich, Patricia F. , Shin, Alexander Y. , Bishop, Allen T.

Mayo Clinic

Journal of Reconstructive Microsurgery | August 30, 2019 | Volume: 36 | Issue: 02 | Pages: 082-092

10.1055/s-0039-1695052 | PMID 31470456 Get It

Background Bone vascularized composite allotransplantation (VCA) is a possible alternative for the treatment of large bone defects. Clinical application of VCAs is limited by the need for life-long immunosuppression (IS). We report an alternative method to maintain bone allotransplant viability in a large animal model without the need for life-long IS by using autogenous vessel implantation. Methods Fourteen bone only VCAs were transplanted in a porcine tibia defect model with short-term IS. Two groups were used to evaluate the effect of the implantation of an autogenous arteriovenous (AV)-bundle, therefore the only difference between the groups was the patency of the AV-bundle. We radiographically evaluated bone healing and allogenic pedicle patency. AV-bundle patency and union were evaluated with micro-CT. Bone remodeling was assessed with histomorphometry and material properties were evaluated with axial compression testing and cyclic reference point indentation. Results Two subjects did not reach the final time point. Twelve tibiae healed proximally, and nine at the distal transplant–bone interface. Bone allotransplants showed their viability in the first 4 to 6 weeks by significant periosteal bridging arising from the transplant and maintained pedicle patency. Bone material properties were not affected by the implantation of an AV-bundle when compared with ligated AV-bundle controls, but diminished compared with normal bone. Significantly higher bone formation rates resulted from the implantation of a patent AV-bundle. Conclusion New periosteal bone formation and subsequent bone healing result from blood flow through the microsurgically repaired nutrient blood supply, demonstrated by maintained allogenic pedicle patency. The implantation of a patent autogenous AV-bundle has no adverse effect on material properties, but a positive effect on bone remodeling of endosteal surfaces despite thrombosis of the allogenic pedicle. Bone material properties change after transplantation compared with normal bone, although 20-weeks survival time is relatively short for the final evaluation of bone material properties.
Prediction of Short- and Long-Term Mortality in Takotsubo Syndrome: The InterTAK Prognostic Score
Wischnewsky, Manfred , Candreva, Alessandro , Bacchi, Beatrice , Cammann, Victoria L. , Kato, Ken , Szawan, Konrad A. , Gili, Sebastiano , Citro, Rodolfo , Bossone, Eduardo , Franke, Jennifer , Sorici‐Barb, Ioana, Knorr, Maike, Heiner, Susanne, Burgdorf, Christof , Kherad, Behrouz , Tschöpe, Carsten , Sarcon, Annahita, Shinbane, Jerold S., Rajan, Lawrence, Michels, Guido, Pfister, Roman , Cuneo, Alessandro , Jacobshagen, Claudius, Karakas, Mahir , Köenig, Wolfgang , Pott, Alexander , Meyer, Philippe , Arroja, José David , Banning, Adrian , Cuculi, Florim , Kobza, Richard , Fischer, Thomas, Vasankari, Tuija , Airaksinen, Juhani , Napp, L. Christian , Budnik, Monika , Dworakowski, Rafał , MacCarthy, Philip , Osswald, Stefan , Galiuto, Leonarda , Chan, Christina , Bridgman, Paul , Beug, Daniel , El‐Battrawy, Ibrahim , Akın, İbrahim , Gilyarova, Ekaterina, Gilyarov, Mikhail , Kozel, Martin , Winchester, David E. , Ukena, Christian , Poglajen, Gregor , Carrilho‐Ferreira, Pedro , Hauck, Christian , Paolini, Carla , Bilato, Claudio , Prasad, Abhiram , Rihal, Charanjit S. , Bianco, Matteo , Jörg, Lucas, Rickli, Hans , Kobayashi, Yoshio, Böhm, Michael , Maier, Lars S. , Pinto, Fausto J. , Widimský, Petr , Borggrefe, Martin, Felix, Stephan B. , Opolski, Grzegorz , Rottbauer, Wolfgang , Pieske, Burkert , Katus, Hugo A. , Horowitz, John D. , Münzel, Thomas , Crea, Filippo , Lüscher, Thomas F. , Ghadri, Jelena R. , Templin, Christian , Gilyarov, Mikhail , Bossone, Eduardo , Citro, Rodolfo , El-Battrawy, Ibrahim , Prasad, Abhiram , Tschöpe, Carsten , Koenig, Wolfgang , Meyer, Philippe , Banning, Adrian , Kobza, Richard , Gilyarov, Mikhail , Ukena, Christian , Bilato, Claudio , D’Ascenzo, Fabrizio , Dichtl, Wolfgang , Neuhaus, Michael, Jaguszewski, Miłosz , Noutsias, Michel , Kaiser, Christoph A. , Delmas, Clément , Lairez, Olivier , Shilova, Alexandra S. , Toušek, Petr , Gałuszka, Jan , Rihal, Charanjit S. , Liu, Kan , Schulze, Paul Christian , Nguyen, Thanh Ha Tuan , Braun-Dullaeus, Ruediger Christian , Hasenfuß, Gerd , Schunkert, Heribert , Thiele, Hölger , Bauersachs, Johann , Mario, Carlo Di , Bax, Jeroen J. , Ruschitzka, Frank T. , Bianco, Matteo

Mayo Clinic

European Journal of Heart Failure | August 27, 2019 | Volume: 21 | Issue: 11 | Pages: 1469-1472

10.1002/ejhf.1561 | PMID 31452320 Get It